ALUNNO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 2.457
AS - Asia 1.399
EU - Europa 1.310
SA - Sud America 226
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 5.423
Nazione #
US - Stati Uniti d'America 2.418
SG - Singapore 624
RU - Federazione Russa 314
IE - Irlanda 274
CN - Cina 267
BR - Brasile 196
HK - Hong Kong 145
DE - Germania 131
TR - Turchia 130
VN - Vietnam 126
IT - Italia 119
SE - Svezia 105
UA - Ucraina 86
GB - Regno Unito 63
NL - Olanda 60
FR - Francia 54
FI - Finlandia 39
IN - India 28
CA - Canada 23
JP - Giappone 13
PL - Polonia 13
BD - Bangladesh 11
BE - Belgio 11
AR - Argentina 10
IQ - Iraq 10
ID - Indonesia 9
ES - Italia 7
PK - Pakistan 7
MX - Messico 6
CO - Colombia 5
NP - Nepal 5
ZA - Sudafrica 5
AU - Australia 4
CH - Svizzera 4
DZ - Algeria 4
EC - Ecuador 4
EU - Europa 4
MA - Marocco 4
PH - Filippine 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
AT - Austria 3
DK - Danimarca 3
HN - Honduras 3
LT - Lituania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DM - Dominica 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
NE - Niger 1
NG - Nigeria 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SM - San Marino 1
SN - Senegal 1
TW - Taiwan 1
Totale 5.423
Città #
Jacksonville 326
Singapore 323
Chandler 315
San Jose 294
Dublin 266
Dallas 202
Ashburn 152
Hong Kong 144
Santa Clara 123
Boardman 105
Izmir 78
New York 70
The Dalles 64
Moscow 60
Amsterdam 54
Beijing 53
Nanjing 53
Wilmington 53
Lawrence 48
Princeton 48
Ho Chi Minh City 44
Los Angeles 36
San Mateo 34
Ann Arbor 27
Hanoi 27
Milan 23
L'aquila 22
Lauterbourg 22
Frankfurt am Main 21
São Paulo 21
Nanchang 20
Munich 16
Pescara 16
Seattle 16
Des Moines 15
Hefei 15
Shanghai 15
Dearborn 14
Columbus 12
Chennai 11
Council Bluffs 11
Woodbridge 11
Helsinki 10
Rome 10
Verona 10
Warsaw 10
Jiaxing 9
Norwalk 9
Tianjin 9
Tokyo 9
Chicago 8
Brussels 7
Hebei 7
Jakarta 7
Mountain View 7
Orem 7
Rio de Janeiro 7
Toronto 7
Brooklyn 6
Da Nang 6
Lappeenranta 6
London 6
Manchester 6
Montreal 6
Philadelphia 6
San Francisco 6
Brasília 5
Haiphong 5
Pune 5
Zhengzhou 5
Atlanta 4
Baghdad 4
Bangkok 4
Belo Horizonte 4
Berlin 4
Bremen 4
Changsha 4
Dong Ket 4
Falkenstein 4
Hangzhou 4
Hải Dương 4
Leuven 4
Ningbo 4
Nuremberg 4
Shenyang 4
Stockholm 4
Ankara 3
Bogotá 3
Bragança Paulista 3
Bắc Ninh 3
Cape Town 3
Cedar Knolls 3
Denver 3
Dhaka 3
Falls Church 3
Feira de Santana 3
Forest City 3
Gravataí 3
Guayaquil 3
Jacareí 3
Totale 3.587
Nome #
12-MONTH OUTCOMES IN OVERWEIGHT/OBESE USERS WITH MENTAL DISORDERS FOLLOWING A MULTI-ELEMENT TREATMENT INCLUDING DIET, PHYSICAL ACTIVITY, AND POSITIVE THINKING: THE REAL-WORLD ‘AN APPLE A DAY’ CONTROLLED TRIAL 174
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 158
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 138
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 130
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 129
SpA plus IBD or IBD plus SpA: Does commutative property apply? 127
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 123
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 123
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 116
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 112
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 110
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 109
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 107
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 107
EFFICACY AND SAFETY OF RITUXIMAB ORIGINATOR AND BIOSIMILAR IN PRIMARY SJOGREN'S SYNDROME IN A REAL-LIFE SETTING 107
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 105
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 105
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo‥gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 104
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 104
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 104
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 104
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 104
CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJOGREN'S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET 103
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 102
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 98
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome 97
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 97
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 96
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 95
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 94
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 93
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 92
Rischio cardiovascolare nei pazienti affetti da malattie infiammatorie croniche: valutazione della relazione tra meccanismi immunologici, profilo metabolico e stile di vita 89
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 88
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 87
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 86
Rituximab in primary Sjögren's syndrome: a ten-year journey 85
Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome 85
Histopathology of salivary glands 85
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis 85
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 85
Characteristics of primary sjögren’s syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS 84
IL-17 PRODUCING DOUBLE NEGATIVE (DN) T CELL PHENOTYPE AND FUNCTION IN PRIMARY SJÖGREN'S SYNDROME 84
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 83
The impact of fibromyalgia in spondyloarthritis: From classification criteria to outcome measures 83
Thymic Stromal Lymphopoietin (TSLP) as a Biomarker of Primary Sjogren's Syndrome (pSS) and Related Lymphoma: Results in Independent Cohorts 81
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans. 79
THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease 72
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience 70
PREVALENCE AND PREDICTIVE ROLE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN A COHORT OF SJÖGREN'S SYNDROME PATIENTS 70
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 68
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 68
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 67
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndrome 64
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 60
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 58
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 54
Totale 5.487
Categoria #
all - tutte 24.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 14 69 15
2021/2022263 10 11 38 24 8 10 2 15 24 8 24 89
2022/2023810 69 44 17 89 86 96 0 46 318 8 29 8
2023/2024232 23 13 11 18 24 80 1 13 1 14 5 29
2024/20251.121 38 20 99 62 104 99 202 78 221 44 90 64
2025/20261.937 110 195 148 190 189 136 378 75 268 248 0 0
Totale 5.487